Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-007638

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
William Lis
Officer — Chief Executive Officer · Director
Period of report
Jan 27, 2015
Accepted (ET)
Jan 29, 2015 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 27, 2015A27,500$0.00A27,500D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$29.72Jan 27, 2015A130,000A—Jan 26, 2025Common Stock130,000130,000D
Performance Stock UnitF3—Jan 27, 2015A70,000A—Jan 27, 2019Common Stock70,00070,000D

Explanation of responses